UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000029854 |
|---|---|
| Receipt number | R000033998 |
| Scientific Title | Phase 1 study of immune checkpoint inhibitor Nivolumab in combination with Bezafibrate in pretreated advanced non-small cell lung cancer |
| Date of disclosure of the study information | 2017/11/07 |
| Last modified on | 2020/04/09 17:49:21 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/11/07 10:47:21 | ||
| 2 | Update | 2018/03/09 10:46:08 | Condition |
|
| 3 | Update | 2018/03/09 10:48:47 | Institutions |
|
| 4 | Update | 2018/03/09 10:49:19 | Recruitment status |
|
| 5 | Update | 2018/11/12 13:16:19 | Public title Acronym |
|
| 6 | Update | 2018/11/12 13:18:49 | Classification by specialty Key secondary outcomes |
|
| 7 | Update | 2018/11/12 13:21:19 | Interventions/Control_1 Interventions/Control_1 |
|
| 8 | Update | 2019/04/01 14:29:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Institutions |
|
| 9 | Update | 2019/07/23 15:51:06 | Recruitment status Date of IRB Last follow-up date |
|
| 10 | Update | 2019/09/30 10:38:55 | Number of participants that the trial has enrolled |
|
| 11 | Update | 2019/11/08 10:01:06 | Recruitment status |
|
| 12 | Update | 2020/04/09 17:49:21 | UMIN ID1 |
